Report Cover

United States Autacoids and Related Drugs Market Report & Forecast 2021-2027


United States Autacoids and Related Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Autacoids and Related Drugs Market Segment Percentages, By Type, 2020 (%)
    Polypeptides
    Decarboxylated Amino Acids
    Eicosanoids

United States Autacoids and Related Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Autacoids and Related Drugs Market Segment Percentages, By Application, 2020 (%)
    Allergies
    Inflammation
    Gastric Acid Secretion
    Neuroendocrine Regulation
    Chronic Pain
    Cardiovascular Diseases
    Gastrointestinal Diseases

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autacoids and Related Drugs revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Autacoids and Related Drugs revenues share in United States market, 2020 (%)
Key companies Autacoids and Related Drugs sales in United States market, 2016-2021 (Estimated), (K Units)
Key companies Autacoids and Related Drugs sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bedford Laboratories
    Bristol-Myers Squibb
    Fresenius
    Abbott Laboratories
    Sanofi
    AstraZeneca
1 Introduction to Research & Analysis Reports
    1.1 Autacoids and Related Drugs Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Autacoids and Related Drugs Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Autacoids and Related Drugs Overall Market Size
    2.1 United States Autacoids and Related Drugs Market Size: 2021 VS 2027
    2.2 United States Autacoids and Related Drugs Revenue, Prospects & Forecasts: 2016-2027
    2.3 United States Autacoids and Related Drugs Sales: 2016-2027

3 Company Landscape
    3.1 Top Autacoids and Related Drugs Players in United States Market
    3.2 Top United States Autacoids and Related Drugs Companies Ranked by Revenue
    3.3 United States Autacoids and Related Drugs Revenue by Companies
    3.4 United States Autacoids and Related Drugs Sales by Companies
    3.5 United States Autacoids and Related Drugs Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Autacoids and Related Drugs Companies in United States Market, by Revenue in 2020
    3.7 Manufacturers Autacoids and Related Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Autacoids and Related Drugs Players in United States Market
        3.8.1 List of Tier 1 Autacoids and Related Drugs Companies in United States
        3.8.2 List of Tier 2 and Tier 3 Autacoids and Related Drugs Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Autacoids and Related Drugs Market Size Markets, 2021 & 2027
        4.1.2 Polypeptides
        4.1.3 Decarboxylated Amino Acids
        4.1.4 Eicosanoids
    4.2 By Type - United States Autacoids and Related Drugs Revenue & Forecasts
        4.2.1 By Type - United States Autacoids and Related Drugs Revenue, 2016-2021
        4.2.2 By Type - United States Autacoids and Related Drugs Revenue, 2022-2027
        4.2.3 By Type - United States Autacoids and Related Drugs Revenue Market Share, 2016-2027
    4.3 By Type - United States Autacoids and Related Drugs Sales & Forecasts
        4.3.1 By Type - United States Autacoids and Related Drugs Sales, 2016-2021
        4.3.2 By Type - United States Autacoids and Related Drugs Sales, 2022-2027
        4.3.3 By Type - United States Autacoids and Related Drugs Sales Market Share, 2016-2027
    4.4 By Type - United States Autacoids and Related Drugs Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Autacoids and Related Drugs Market Size, 2021 & 2027
        5.1.2 Allergies
        5.1.3 Inflammation
        5.1.4 Gastric Acid Secretion
        5.1.5 Neuroendocrine Regulation
        5.1.6 Chronic Pain
        5.1.7 Cardiovascular Diseases
        5.1.8 Gastrointestinal Diseases
    5.2 By Application - United States Autacoids and Related Drugs Revenue & Forecasts
        5.2.1 By Application - United States Autacoids and Related Drugs Revenue, 2016-2021
        5.2.2 By Application - United States Autacoids and Related Drugs Revenue, 2022-2027
        5.2.3 By Application - United States Autacoids and Related Drugs Revenue Market Share, 2016-2027
    5.3 By Application - United States Autacoids and Related Drugs Sales & Forecasts
        5.3.1 By Application - United States Autacoids and Related Drugs Sales, 2016-2021
        5.3.2 By Application - United States Autacoids and Related Drugs Sales, 2022-2027
        5.3.3 By Application - United States Autacoids and Related Drugs Sales Market Share, 2016-2027
    5.4 By Application - United States Autacoids and Related Drugs Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
    6.1 Bedford Laboratories
        6.1.1 Bedford Laboratories Corporation Information
        6.1.2 Bedford Laboratories Overview
        6.1.3 Bedford Laboratories Autacoids and Related Drugs Sales and Revenue in United States Market (2016-2021)
        6.1.4 Bedford Laboratories Autacoids and Related Drugs Product Description
        6.1.5 Bedford Laboratories Recent Developments
    6.2 Bristol-Myers Squibb
        6.2.1 Bristol-Myers Squibb Corporation Information
        6.2.2 Bristol-Myers Squibb Overview
        6.2.3 Bristol-Myers Squibb Autacoids and Related Drugs Sales and Revenue in United States Market (2016-2021)
        6.2.4 Bristol-Myers Squibb Autacoids and Related Drugs Product Description
        6.2.5 Bristol-Myers Squibb Recent Developments
    6.3 Fresenius
        6.3.1 Fresenius Corporation Information
        6.3.2 Fresenius Overview
        6.3.3 Fresenius Autacoids and Related Drugs Sales and Revenue in United States Market (2016-2021)
        6.3.4 Fresenius Autacoids and Related Drugs Product Description
        6.3.5 Fresenius Recent Developments
    6.4 Abbott Laboratories
        6.4.1 Abbott Laboratories Corporation Information
        6.4.2 Abbott Laboratories Overview
        6.4.3 Abbott Laboratories Autacoids and Related Drugs Sales and Revenue in United States Market (2016-2021)
        6.4.4 Abbott Laboratories Autacoids and Related Drugs Product Description
        6.4.5 Abbott Laboratories Recent Developments
    6.5 Sanofi
        6.5.1 Sanofi Corporation Information
        6.5.2 Sanofi Overview
        6.5.3 Sanofi Autacoids and Related Drugs Sales and Revenue in United States Market (2016-2021)
        6.5.4 Sanofi Autacoids and Related Drugs Product Description
        6.5.5 Sanofi Recent Developments
    6.6 AstraZeneca
        6.6.1 AstraZeneca Corporation Information
        6.6.2 AstraZeneca Overview
        6.6.3 AstraZeneca Autacoids and Related Drugs Sales and Revenue in United States Market (2016-2021)
        6.6.4 AstraZeneca Autacoids and Related Drugs Product Description
        6.6.5 AstraZeneca Recent Developments

7 United States Autacoids and Related Drugs Production Capacity, Analysis
    7.1 United States Autacoids and Related Drugs Production Capacity, 2016-2027
    7.2 Autacoids and Related Drugs Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
    8.1 Market Opportunities & Trends
    8.2 Market Drivers
    8.3 Market Restraints

9 Autacoids and Related Drugs Supply Chain Analysis
    9.1 Autacoids and Related Drugs Industry Value Chain
    9.2 Autacoids and Related Drugs Upstream Market
    9.3 Autacoids and Related Drugs Downstream and Clients
    9.4 Marketing Channels Analysis
        9.4.1 Marketing Channels
        9.4.2 Autacoids and Related Drugs Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
    11.1 Note
    11.2 Examples of Clients
    11.3 Author Details
    11.4 Disclaimer

List of Tables Table 1. Key Players of Autacoids and Related Drugs in United States Market Table 2. Top Autacoids and Related Drugs Players in United States Market, Ranking by Revenue (2019) Table 3. United States Autacoids and Related Drugs Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Autacoids and Related Drugs Revenue Share by Companies, 2016-2021 Table 5. United States Autacoids and Related Drugs Sales by Companies, (K Units), 2016-2021 Table 6. United States Autacoids and Related Drugs Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Autacoids and Related Drugs Price (2016-2021) & (USD/Pcs) Table 8. Manufacturers Autacoids and Related Drugs Product Type Table 9. List of Tier 1 Autacoids and Related Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Autacoids and Related Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Polypeptides Table 12. Major Manufacturers of Decarboxylated Amino Acids Table 13. By Type - United States Autacoids and Related Drugs Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Autacoids and Related Drugs Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Autacoids and Related Drugs Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Autacoids and Related Drugs Sales (K Units), 2016-2021 Table 17. By Type - United States Autacoids and Related Drugs Sales (K Units), 2022-2027 Table 18. By Application - United States Autacoids and Related Drugs Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Autacoids and Related Drugs Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Autacoids and Related Drugs Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Autacoids and Related Drugs Sales (K Units), 2016-2021 Table 22. By Application - United States Autacoids and Related Drugs Sales (K Units), 2022-2027 Table 23. Bedford Laboratories Corporation Information Table 24. Bedford Laboratories Description and Major Businesses Table 25. Bedford Laboratories Autacoids and Related Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) Table 26. Bedford Laboratories Autacoids and Related Drugs Product Table 27. Bedford Laboratories Recent Developments Table 28. Bristol-Myers Squibb Corporation Information Table 29. Bristol-Myers Squibb Description and Major Businesses Table 30. Bristol-Myers Squibb Autacoids and Related Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) Table 31. Bristol-Myers Squibb Autacoids and Related Drugs Product Table 32. Bristol-Myers Squibb Recent Developments Table 33. Fresenius Corporation Information Table 34. Fresenius Description and Major Businesses Table 35. Fresenius Autacoids and Related Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) Table 36. Fresenius Autacoids and Related Drugs Product Table 37. Fresenius Recent Developments Table 38. Abbott Laboratories Corporation Information Table 39. Abbott Laboratories Description and Major Businesses Table 40. Abbott Laboratories Autacoids and Related Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) Table 41. Abbott Laboratories Autacoids and Related Drugs Product Table 42. Abbott Laboratories Recent Developments Table 43. Sanofi Corporation Information Table 44. Sanofi Description and Major Businesses Table 45. Sanofi Autacoids and Related Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) Table 46. Sanofi Autacoids and Related Drugs Product Table 47. Sanofi Recent Developments Table 48. AstraZeneca Corporation Information Table 49. AstraZeneca Description and Major Businesses Table 50. AstraZeneca Autacoids and Related Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021) Table 51. AstraZeneca Autacoids and Related Drugs Product Table 52. AstraZeneca Recent Developments Table 53. Autacoids and Related Drugs Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units) Table 54. United States Autacoids and Related Drugs Capacity Market Share of Key Manufacturers, 2019-2021 Table 55. Autacoids and Related Drugs Market Opportunities & Trends in United States Market Table 56. Autacoids and Related Drugs Market Drivers in United States Market Table 57. Autacoids and Related Drugs Market Restraints in United States Market Table 58. Autacoids and Related Drugs Raw Materials Table 59. Autacoids and Related Drugs Raw Materials Suppliers in United States Market Table 60. Typical Autacoids and Related Drugs Downstream Table 61. Autacoids and Related Drugs Downstream Clients in United States Market Table 62. Autacoids and Related Drugs Distributors and Sales Agents in United States Market List of Figures Figure 1. Autacoids and Related Drugs Product Picture Figure 2. Autacoids and Related Drugs Segment by Type Figure 3. Autacoids and Related Drugs Segment by Application Figure 4. United States Autacoids and Related Drugs Market Overview: 2020 Figure 5. United States Autacoids and Related Drugs Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Autacoids and Related Drugs Revenue, 2016-2027 (US$, Mn) Figure 7. Autacoids and Related Drugs Sales in United States Market: 2016-2027 (K Units) Figure 8. The Top 3 and 5 Players Market Share by Autacoids and Related Drugs Revenue in 2020 Figure 9. Polypeptides Product Picture Figure 10. Decarboxylated Amino Acids Product Picture Figure 11. Eicosanoids Product Picture Figure 12. By Type - United States Autacoids and Related Drugs Sales Market Share, 2016-2027 Figure 13. By Type - United States Autacoids and Related Drugs Revenue Market Share, 2016-2027 Figure 14. By Type - United States Autacoids and Related Drugs Price (USD/Pcs), 2016-2027 Figure 15. Allergies Figure 16. Inflammation Figure 17. Gastric Acid Secretion Figure 18. Neuroendocrine Regulation Figure 19. Chronic Pain Figure 20. By Application - United States Autacoids and Related Drugs Sales Market Share, 2016-2027 Figure 21. By Application - United States Autacoids and Related Drugs Revenue Market Share, 2016-2027 Figure 22. By Application - United States Autacoids and Related Drugs Price (USD/Pcs), 2016-2027 Figure 23. Bedford Laboratories Autacoids and Related Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Bristol-Myers Squibb Autacoids and Related Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. Fresenius Autacoids and Related Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Abbott Laboratories Autacoids and Related Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Sanofi Autacoids and Related Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. AstraZeneca Autacoids and Related Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. United States Autacoids and Related Drugs Production Capacity (K Units), 2016-2027 Figure 30. Autacoids and Related Drugs Industry Value Chain Figure 31. Marketing Channels

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us